Royal College of Surgeons of Edinburgh launches MRCS ophthalmology exam, Fellowship to follow

Article

A new MRCS ophthalmology examination will be offered to ICO College Members beginning in 2022.

Royal College of Surgeons of Edinburgh launches MRCS ophthalmology exam, Fellowship to follow

The Royal College of Surgeons of Edinburgh (RCSEd), a leading surgical college, announced the launch of its own Membership of the Royal College of Surgeons (MRCS) ophthalmology examination.

This new examination will be available in early 2022, and a Fellowship examination will follow later in the year.

Professor Michael Griffin OBE, President of the RCSEd

Professor Michael Griffin OBE

“We would like to thank the ICO for the very positive relationship we have enjoyed over the last few years and wish them the best in their pursuit of improving standards in global Ophthalmology care,” said Professor Michael Griffin OBE, President of the RCSEd. “We are delighted to now have the opportunity to launch our very own MRCS Ophthalmology and look forward to adding a Fellowship examination next year, ensuring those in the profession will have a continued route into College membership.”

RCSEd was first incorporated as the Barber Surgeons of Edinburgh in 1505, and it has since grown to nearly 29,000 members from 100 countries worldwide, with 15,000 in the UK. As one of the oldest surgical corporations in the world, the College promotes the high standards in surgical and dental practice. The College is also home of the UK’s only Faculty of Surgical Trainers, which is open to anyone with interest in surgical training, regardless of College affiliation.

All ICO College Members—including the April intake of this year—are eligible for the full benefits and services the College offers.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.